Powered by

PHARMA FIRMS MERGE AMID BRUTAL COMPETITION : MYLAN-UPJOHN COULD GO BIG ON GENERICS

Aug 04, 2019 - Pittsburgh Post-Gazette

Drugmaker Mylan's planned tie-up with the Upjohn unit of pharmaceutical giant Pfizer Inc. comes at a time of "massive and sustained generic price deflation," according to an industry consultant.

Whether the as-yet-unnamed Mylan-Upjohn outfit succeeds turns on how well Pfizer can essentially compete against itself in maximizing revenue from branded drugs losing their patent protection.

The outcome will determine the future of the new company's facilities, including Mylan's onetime exe...